Document is current
Any future updates will be listed below
-
Authors
Jiang, Yixiang
Wang, Ning
Liu, Jingyi
Ren, Haoran
Jiang, Wenkang
Lei, Yanting
Fu, Xidan
Hao, Miao
Lang, Xiujuan
Liu, Yumei
Liu, Xijun
Li, Rui
Li, Hulun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82271845, 82371821)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 23 January 2025
First Online: 4 February 2025
Declarations
:
: The hMSCs used in the study were provided by the Department of Obstetrics at the Second Affiliated Hospital of Harbin Medical University. And the hMSCs were extracted from medical waste (umbilical cords) and donated to our laboratory for the purpose of scientific research. All experimental protocols and procedures were approved by the Institutional Animal Care and Use Committee of Harbin Medical University on September, 2021 (Project title: Efficacy and mechanism of hMSC-derived supernatant administered intranasally in the treatment of experimental ischemic stroke) and carried out in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Ethics Committee did not issue approval numbers.
: Written informed consent for publication was obtained from all participants.
: The authors declare that they have no competing interests.
